Donald Trump: What medtech’s top executives are saying

“I would like to offer a summary of the components that we are encouraging lawmakers to consider in any new or reformed healthcare law. First, we are advocating for important elements like increased access, coverage of pre-existing conditions and coverage of young people on their parents’ health plan to continue in the future. Second, we believe that any ACA replacement must support a competitive market for individual health insurance. We will continue to advocate for models that encourage innovation and value, continuing the move towards value-based care and payment for improved patient outcomes. Finally, we support reforms and emphasize wellness and intercepting disease before it happens. Preventive care, more latitude for employer wellness programs and incentives for healthy behaviors are great ways to embody this focus. Outside the U.S., healthcare systems are evolving as well and we will continue to be a champion for improving patient outcomes and investing in healthy societies.

“We know that when governments invest in healthcare, they see a return on that investment in the form of worker productivity, economic growth and stability. In addition to advocating for all these healthcare priorities as a U.S.-based multinational company, we also are advocating for the modernization of the U.S. tax codes. As both sides in the aisle in the Washington have noted, the U.S. tax code for business is outdated and in many cases makes the U.S. a more costly place to do business leaving U.S. workers and the U.S. economy at a disadvantage.

“We are very encouraged by the proposals currently in discussion, and we will support business tax policy that is competitive with most developed countries and encourages innovation and growth. This includes a system based on territorial taxation in line with most economically developed nations.

“We also believe that there should be incentives for innovations such as research and development and the cash currently held abroad should be allowed to be brought back into the US at a more competitive tax rate. Regardless of the outcome of these discussions, we will continue to engage with global leaders and continue to be a leading voice advocating for the stakeholders in our Credo” —Johnson & Johnson CEO Alex Gorsky, Jan. 24

Next>>

Pages: 1 2 3 4 5 6 7 8